Copeptin and Psychological Stress of Medic During COVID-19 Pandemic
COVID-19
Evaluation of Serum Copeptin and Psychological Stress Level Among Healthcare Providers During COVID-19 Pandemic
1 other identifier
observational
90
1 country
1
Brief Summary
Psychological stress (PSS) is one of the most common problems among healthcare providers during COVID-19 pandemic. PSS influences the homeostatic equilibrium of the body, involving activation of the sympathetic nervous system and hypothalamus pituitary adrenal (HPA) axis. Copeptin; C-terminal portion of Vasopressin (AVP) precursor is stable. Nevertheless, Evidence about influence of PSS on copeptin levels is lacking. The reason we are doing this research is to determine the level of psychological stress among healthcare providers exposed to at the time of work in intensive care unit (ICU) during COVID-19 pandemic; They will be appraised every assembly for psychological stress level; before start of duty shifts (first time), one week after start (second time) and two weeks after departure from shift duties in ICU (third time) for assessment of psychological stress level and stress hormones.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2020
CompletedFirst Submitted
Initial submission to the registry
February 6, 2021
CompletedFirst Posted
Study publicly available on registry
February 17, 2021
CompletedFebruary 17, 2021
February 1, 2021
6 months
February 6, 2021
February 15, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
evaluation of psychological stress
\- Primarily outcome determination of psychological stress among doctors and nurses working in ICU through a questionnaire before duty shifts \[first time\] and re-evaluate it after one week of work in ICU \[second time\], and lastly two weeks after departure from shift duties \[third time\].
four weeks for each participant.
determine stress hormones in serum cortisol and copeptin
Second to determine stress hormones copeptin and cortisol (possible stress biomarkers) concurrently with questionnaire.
four weeks for each participant..
Secondary Outcomes (1)
correlation of psychological stress with stress hormone copeptin
four weeks for each participant..
Study Arms (2)
control group
25 healthcare personnel volunteers not working in quarantine hospitals of matched age
healthcare providers worked in Intensive Care Units
35 physicians (28 males and 7 females) and 35 nurses (10 males and 25 females). All volunteers were in good physical health Exclusion criteria included hypertension, diabetes mellitus, obesity BMI ≥30, subjects with serum sodium ≤135 or ≥ 145 mmol /L at baseline or females receiving contraceptive pills. Assigned participants were clinically evaluated for as hypertension, DM, dyslipidemia, renal function.
Eligibility Criteria
Healthcare providers worked in ICU: 35 physicians (28 males and 7 females) and 35 nurses (10 males and 25 females). Age ranged from 24 to 37 years All volunteers were in good physical health Exclusion criteria included hypertension, diabetes mellitus, obesity BMI ≥30, subjects with serum sodium ≤135 or ≥ 145 mmol /L at baseline or females receiving contraceptive pills. Group Information healthcare providers designated to take duty shifts at ICU in Alexandria quarantine hospitals for two weeks during COVID-19 pandemic. And a control group of healthcare providers not assigned to work in quarantine hospitals. First assembly one day before enrolling to work in ICU. Second assembly at the end of first week of work, third assembly two weeks after departure from work in ICU
You may qualify if:
- physicians and nurses under age of 37 years in good health
You may not qualify if:
- body mass index above 30
- hypertension
- Diabetes mellitus
- females receiving contraceptive pills
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Alexandria University Faculty of Medicine
Alexandria, 21311, Egypt
Related Publications (2)
McEwen BS. Protective and damaging effects of stress mediators: central role of the brain. Dialogues Clin Neurosci. 2006;8(4):367-81. doi: 10.31887/DCNS.2006.8.4/bmcewen.
PMID: 17290796RESULTChrist-Crain M, Fenske W. Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis. Nat Rev Endocrinol. 2016 Mar;12(3):168-76. doi: 10.1038/nrendo.2015.224. Epub 2016 Jan 22.
PMID: 26794439RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 4 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant Clinical Pathology
Study Record Dates
First Submitted
February 6, 2021
First Posted
February 17, 2021
Study Start
May 10, 2020
Primary Completion
October 30, 2020
Study Completion
October 30, 2020
Last Updated
February 17, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share